Skip to content

Cryolesion in Treatment of Phantom Limb Pain

Percutaneous Cryoablation in the Treatment of Neuropathic Pain Post Limb Amputation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03415360
Enrollment
50
Registered
2018-01-30
Start date
2018-02-09
Completion date
2020-01-31
Last updated
2018-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Phantom, Phantom Limb Pain, Stump Neuralgia

Keywords

cryoablation

Brief summary

Assessment of pain intensity on the NRS. Assessment of the quality of life by SF-36 and AIS. Diagnostic/prognostic nerve block with 5 ml of 2% lidocaine under real-time ultrasound control with confirmation of the correct position of the needle using a peripheral nerve stimulator. Reassessment of pain intensity on the NRS 30 minutes after local anesthetic block. Cryoablation under real-time ultrasound control if the NRS value is reduced by ≥ 2 points. If pain intensity on the NRS reduced by less than 2 points, reassessment 60 minutes after local anesthetic block. Cryoablation under real-time ultrasound control if the NRS value is reduced by ≥ 2 points. If pain intensity on the NRS reduces by less than 2 points 60 minutes after local anesthetic block cryoablation will not be performed. Cryoablation effect will be evaluated 24 hours, 7 days, 30 days, 3 months, 6 months post procedure. * 24 hours after the procedure - assessment of pain intensity and quality of life * 7 days after the procedure - assessment of pain intensity * 30 days after the procedure - assessment of pain intensity and quality of life * 3 months after the procedure - assessment of pain intensity * 6 months after the procedure - assessment of pain intensity and quality of

Interventions

PROCEDUREcryoablation

cryoablation of nerve responsible for phantom limb pain

Sponsors

Military Institute od Medicine National Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single Group Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Status post amputation of a lower or upper limb * Pain related to amputation as determined by referring physician and investigator * Informed consent of patient to enter the study * Reduction of pain after the diagnostic/prognostic anesthetic block of the relevant main peripheral nerves under ultrasonography guidance in an analogous fashion to the cryoablation procedure

Exclusion criteria

* Pregnancy * Active infection in the area of the planned intervention * Blood coagulation disorders * Immunosuppression * Significant spinal stenosis or spinal anomalies that result in differential nerve root pressures * Significant disease or disorder that in the opinion of the Principal Investigator would preclude the safe performance of the anesthetic block or cryoablation * Participation in another investigational trial involving systemic administration of agents of unknown chemical composition. * No reduction of pain after the diagnostic block of the relevant main peripheral nerves

Design outcomes

Primary

MeasureTime frameDescription
Reduction of painT1: before cryoablation; T2: 24 hours after cryoablation; T3: 7 days after cryoablation; T4: 30 days after cryoablation; T5: 3 months after cryoablation; T6: 6 months after cryoablation.Assessment of pain intensity pre- and post - cryoablation on the NRS (numeric rating scale). Numeric Rating Scale (NRS) is a unidimensional measure of pain intensity in adults. This is a 11-point numeric scale ranges from '0' (minimum, no pain) to '10' (maximum, pain as bad as one can imagine). The lower the NRS value, the better clinical outcome.

Secondary

MeasureTime frameDescription
The quality of life (SF-36)A1: before cryoablation; A2: 24 hours after cryoablation; A3: 30 days after cryoablation; A4: 6 months after cryoablation.Assessment of the quality of life pre- and post - cryoablation on SF-36. 36-Item Short Form Survey (SF-36) is a 36-item questionnaire which measures quality of life across eight domains: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health. For each of the eight domains that the SF36 measures an aggregate percentage score is produced. The percentage scores range from 0% (lowest or worst possible level of functioning) to 100% (highest or best possible level of functioning).
The quality of life (AIS)A1: before cryoablation; A2: 24 hours after cryoablation; A3: 30 days after cryoablation; A4: 6 months after cryoablation.Assessment of the quality of life pre- and post - cryoablation on AIS. The Acceptance of Illness Scale (AIS) consists of eight statements describing negative impact of poor health status and its consequences for patients' functioning. The scoring for each statement varies from 1 (poor adaptation to the disease) to 5 (full acceptance of the disease). The total score ranges between 8 and 40. The lower score, the poorer acceptance of disease and more severe restrictions caused by condition. A high score means acceptance of patient's own health status and lack of negative emotions related to illness.

Countries

Poland

Contacts

Primary ContactDariusz Tomaszewski, MD PhD
dtomaszewski@wim.mil.pl00 48501 190 386
Backup ContactJaroslaw J Les, MD PhD
jles@wim.mil.pl00 48 695 926 026

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026